INTEGRA LIFESCIENCES HOLDINGS CORP — Form 8-K
Filed October 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 24/100
What the filing says
On October 19, 2026, Integra LifeSciences Holdings Corporation issued $450.0 million in aggregate principal amount of 9.500% Senior Secured Notes due 2033 under an indenture with Truist Bank as trustee and collateral agent. The Notes are secured by collateral and guaranteed by subsidiary guarantors, with an interest rate of 9.5% per annum. This is a debt financing transaction with standard covenant restrictions on restricted payments, asset sales, liens, and indebtedness incurrence.
Why this rating
Debt issuance of $450M (~49% of company's $925M market cap) is material in absolute terms but typical capital structure financing for established company; routine disclosure of indenture terms.
See more from October 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.